GuideAugust 9, 2026 · 1 min read

KPV vs BPC-157: Anti-Inflammatory Tripeptide vs Repair Pentadecapeptide

Research compounds for laboratory use only · not medical advice

Comparing KPV (Lys-Pro-Val) and BPC-157 — two peptide research directions for inflammation and tissue repair, and how their mechanisms differ.

KPV and BPC-157 are often mentioned together because they live in the same corner of peptide research — tissue recovery — but they work through very different designs: a three-amino-acid anti-inflammatory fragment versus a fifteen-amino-acid repair peptide.

The molecules

KPV BPC-157
Sequence Lys-Pro-Val (3 aa) Pentadecapeptide (15 aa)
Origin C-terminal fragment of α-MSH Sequence from gastric juice protein
MW ≈ 342 g/mol ≈ 1419 g/mol
Research focus Inflammatory modulation Tissue repair / angiogenesis

KPV: the anti-inflammatory arm

KPV’s research profile centers on NF-κB-associated signaling and cytokine modulation — the inflammatory-tone side of the recovery story. It appears in epithelial barrier and mucosal integrity studies, and its minimal size makes it a focused probe for anti-inflammatory peptide signaling without melanocortin pigmentation activity.

BPC-157: the repair arm

BPC-157’s research is dominated by angiogenesis, tendon and ligament fibroblast activity, and gastrointestinal mucosal protection. It is one of the most-studied peptides in regenerative research, referenced across wound-healing and tissue-repair models.

How they complement each other

Inflammation and repair are two phases of the same tissue response, which is why the two peptides show up together in the GLOW research blend (BPC-157 + GHK-Cu + TB-500) and its KLOW extension with KPV — pairing a repair scaffold with an anti-inflammatory arm for combined regenerative studies.

Handling notes

Both are lyophilized and reconstituted with bacteriostatic water; the reconstitution calculator handles the liquid math.

See KPV and BPC-157 for CAS, purity and full specifications.

For laboratory research use only. Not medical advice.

Last updated September 9, 2026

FAQ

Frequently asked questions

What is the difference between KPV and BPC-157?

KPV is the anti-inflammatory C-terminal tripeptide of α-MSH, studied for cytokine modulation and epithelial barrier support. BPC-157 is a 15-amino-acid pentadecapeptide studied for angiogenesis, tendon fibroblast activity and gastrointestinal mucosa repair.

Are KPV and BPC-157 used together?

They appear together in research blends — the GLOW/KLOW combinations pair BPC-157's repair profile with KPV's anti-inflammatory arm for multi-pathway regenerative studies.

Which is for inflammation and which for repair?

KPV's research focus is inflammatory modulation (NF-κB and cytokine signaling); BPC-157's is structural repair (angiogenesis and tissue regeneration). They are complementary rather than interchangeable.